








Key findings from the ‘Australians’ Drug Use: 
Adapting to Pandemic Threats’ (ADAPT) Study
What are the aims of the ADAPT Study? 
The Australians' Drug Use: Adapting to Pandemic
Threats (ADAPT) Study is exploring the short and
long-term impact of the COVID-19 pandemic on
the experiences of Australians who use illicit
drugs. Findings will be used to ensure drug-related
issues during COVID-19 are better understood and
more accurately represented, so as to better
inform drug treatment and harm reduction in
Australia.
What does the ADAPT Study involve? 
Australians who regularly (i.e. at least once a
month) used illicit drugs in 2019 were invited to
complete an online survey initially and follow-
up surveys in 2 months, 4 months, 6 months,
12 months, 2 years and 3 years. Participants
could opt to complete the Wave 1 survey only.
What have we found so far? 
The information below outlines findings from the
702 eligible participants who completed the
Wave 1 survey from 29 April to 15 June 2020.
The ADAPT sample mostly comprised
young, well-educated (62% completed
tertiary/university qualification) capital city
dwellers, although notably one-quarter
(25%) of participants reported living in
regional/rural/remote areas.
Participants were recruited from:
Participants ranged in age from 18-67, with
a median age of 25 years. Similar
proportions of men and women took part,
with 4% of participants identifying as non-
binary.
WAVE 1 BULLETIN JUNE 2020
10%
of the sample 
were tested for 
COVID-19
COVID-19 STATUS
Most participants (86%) reported
that they had not experienced any
COVID-19 symptoms, nor been
tested, at the time of interview. 10%
had been tested, with no
participants reporting that they had
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e-cigarettes & LSD had
most commonly
remained stable since
the beginning of March.
MDMA, cocaine and
ketamine use had most
commonly decreased since




Cannabis and alcohol use
had most commonly
increased since the
beginning of March (i.e.,
since COVID-19 restrictions)
as compared to before.
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Most commonly used drugs post 
COVID-19 restrictions*
Drug of Choice













*Other includes ketamine (4%), heroin (3%), pharmaceutical   
opioids (3%), other (2%), benzodiazepines (1%), GHB (<1%), 





Cocaine (30%)was the most 
common drug of 
choice
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Most participants continued to
receive their drugs in person (76%
in Feb 2020 vs 66% past month).
There was a small increase in the
proportion of participants who had
their illicit drugs delivered to them
(36% Feb 2020 vs 41% past month).
There was a small increase in those
who did not obtain illicit drugs post
March 2020 (4% in Feb 2020 vs 10%
in past month).
8% reported injecting any drug 
since the beginning of March 2020 
(10% past year, 16% lifetime) 
DRUG USE BEHAVIOURS HARM REDUCTION (HR) BEHAVIOURS 
TREATMENT ACCESS & ENGAGEMENT
4%
Had accessed drug 
treatment in the 
past four weeks
3%
Tried but were 
unable to access 
drug treatment
8%
Tried but were 




Had accessed help 
for mental health 
reasons in the past 
four weeks
Drug Treatment since March 2020
Treatment engagement was low. Of 
those who answered (n=593):
Mental health services since March 2020







Mental health (n=592)             Physical health (n=567)
CHANGES IN HEALTH RATINGS
Participants’ mental health and physical 
health ratings in the past month vs February 
2020 (pre COVID-19 restrictions)
In response to COVID-19 restrictions (i.e.,

























Note: 10% reported engaging in other HR behaviours, and 
30% reported engaging in none of the listed HR behaviours. 
4% reported an overdose since the beginning of March 2020 (13% 
past year, 31% lifetime)DRUG-RELATED HARMS
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SUMMARY
• The ADAPT sample comprised mostly young, well-educated capital city dwellers. Being a
convenience sample, findings from the ADAPT study cannot be considered representative of
all people that use drugs.
• Cannabis and alcohol use had most commonly increased relative to before March 2020,
while use of MDMA, cocaine and ketamine had most commonly decreased.
• Participants reported engaging in a range of behaviours to reduce the risk of contracting
COVID-19 and/or minimise impact of COVID-19 restrictions since March 2020, including
washing hands before handling drugs/money and avoiding sharing drug equipment.
• More than half of participants reported poorer mental health in the past four weeks relative
to before March 2020, with almost two-fifths reporting that they had accessed help for
mental health reasons in the past four weeks.
• A small proportion of the sample reported that they had tried but been unable to access
drug treatment and/or mental health services post March 2020.
• It is critical to continue to monitor the impacts of COVID-19 on different populations who
use drugs (e.g., through the SuperMIX and IDRS interviews with people who regularly inject
drugs).
• Findings from future surveys of the ADAPT sample will be reported on in future outputs.
• The participants who contributed their valuable time to share their experiences.
• The Australian Injecting & Illicit Drug Users League (AIVL) for their support and advice
in developing the project.
• All those who gave advice and shared information about the project.
• The National Drug and Alcohol Research Centre and the Australian Government
Department of Health for funding support.
• Email adaptstudy@unsw.edu.au
• Check out our website at 
www.adaptstudy.org.au
• Follow @NDARCNews or 
#ADAPTStudy on Twitter
• Follow ADAPT Study on Facebook
